Wave Life Sciences Ltd. (WVE) Market Cap & Valuation Ratios
Wave Life Sciences Ltd. (WVE) has a market cap of $626.6M and a price-to-sales ratio of 9.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WVEWave Life Sciences Ltd.Follow WVE — free
—
Price chart with a free account
- Market cap
- 626.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 15 days
Peers
biotechnology · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| WVE | 0.6 | — | 4.0 | — | — | -30% | -333% | -255% |
| ACHV | 0.7 | — | — | — | -7.4% | — | — | — |
| PRME | 0.7 | — | 140.1 | — | — | -18% | — | — |
| AURA | 0.7 | — | — | — | — | — | — | -88% |
| DSGN | 0.6 | — | — | — | -8.6% | — | — | -42% |
| SLDB | 0.6 | — | — | — | — | — | — | -127% |
| LXRX | 0.6 | — | 11.9 | — | -10.3% | -29% | -131% | -30% |
| CADL | 0.6 | — | — | — | -9.3% | — | — | — |
| CRMD | 0.6 | 3.8 | 1.1 | 2.0 | — | +281% | 47% | 57% |
| SGMT | 0.6 | — | — | — | -7.0% | — | — | -59% |
| CLYM | 0.6 | — | — | — | -9.3% | — | — | -36% |
| Median of these 10 | 3.8 | 11.9 | 2.0 | -9.0% | -18% | -42% | -42% |
; EV/Sales 4.0 vs. 11.9.
Growth vs. price
each dot a company · hover or tap for valuesWave Life Sciences Ltd. — questions
- What is Wave Life Sciences Ltd.'s market cap?
- $626.6M.
- What is Wave Life Sciences Ltd.'s price-to-sales ratio?
- 9.6.
Every figure on this page comes from Wave Life Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.